Award details

New molecules in signalling pathways for lymphocyte development

ReferenceBBS/E/B/0000C206
Principal Investigator / Supervisor Dr Martin Turner
Co-Investigators /
Co-Supervisors
Institution Babraham Institute
DepartmentBabraham Institute Department
Funding typeResearch
Value (£) 2,903,683
StatusCompleted
TypeInstitute Project
Start date 01/04/2004
End date 31/03/2012
Duration96 months

Abstract

Developing new approaches to manipulate the mammalian immune system represents one of the major challenges for the biotechnology and biological sciences community in the 21st century. The increases in allergic and autoimmune disease coupled with the threat of new and re-emerging infectious diseases means that we must develop strategies which either restrain or augment the function of immune cells. This challenge can only be met if we have a complete understanding of the signalling pathways activated by encounter with an antigen (a molecule that is recognised by the immune system). Consequently, the biochemical and genetic pathways triggered by antigen encounter are the subject of study in our project. Expression (the copying of information encoded in DNA into RNA and then often into protein) of individual signalling molecules is regulated during lymphocyte (a type of white blood cell) development and thus imparts considerable flexibility upon the antigen receptor (which binds to antigens) in terms of the molecules which it can recruit and activate during the lifetime of the lymphocyte. Evaluation of the role of these molecules in lymphocytes is necessary to understand how activation thresholds of the antigen receptor are set.

Summary

unavailable
Committee Closed Committee - Biochemistry & Cell Biology (BCB)
Research TopicsImmunology
Research PriorityX – Research Priority information not available
Research Initiative X - not in an Initiative
Funding SchemeX – not Funded via a specific Funding Scheme
terms and conditions of use (opens in new window)
export PDF file